nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—Dyspnoea exertional—Cladribine—multiple sclerosis	0.0392	0.0698	CcSEcCtD
Phentermine—SLC6A3—nerve—multiple sclerosis	0.0238	0.0834	CbGeAlD
Phentermine—MAOB—nerve—multiple sclerosis	0.0207	0.0726	CbGeAlD
Phentermine—SLC6A2—nerve—multiple sclerosis	0.0192	0.0673	CbGeAlD
Phentermine—MAOA—nerve—multiple sclerosis	0.0177	0.062	CbGeAlD
Phentermine—Cerebrovascular accident—Fingolimod—multiple sclerosis	0.0155	0.0276	CcSEcCtD
Phentermine—Cardiac arrest—Fingolimod—multiple sclerosis	0.0144	0.0257	CcSEcCtD
Phentermine—Pseudoephedrine—IL2—multiple sclerosis	0.0112	0.556	CrCbGaD
Phentermine—SLC6A3—brainstem—multiple sclerosis	0.0102	0.0358	CbGeAlD
Phentermine—SLC6A4—brainstem—multiple sclerosis	0.00937	0.0328	CbGeAlD
Phentermine—MAOB—brainstem—multiple sclerosis	0.00891	0.0312	CbGeAlD
Phentermine—Cardiac failure—Cladribine—multiple sclerosis	0.00881	0.0157	CcSEcCtD
Phentermine—Cerebrovascular accident—Cladribine—multiple sclerosis	0.00877	0.0156	CcSEcCtD
Phentermine—SLC6A2—brainstem—multiple sclerosis	0.00825	0.0289	CbGeAlD
Phentermine—Palpitations—Fingolimod—multiple sclerosis	0.00807	0.0144	CcSEcCtD
Phentermine—Hypertension—Fingolimod—multiple sclerosis	0.00788	0.014	CcSEcCtD
Phentermine—MAOA—brainstem—multiple sclerosis	0.0076	0.0266	CbGeAlD
Phentermine—MAOA—retina—multiple sclerosis	0.00733	0.0257	CbGeAlD
Phentermine—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00676	0.0509	CbGpPWpGaD
Phentermine—SLC6A3—midbrain—multiple sclerosis	0.00651	0.0228	CbGeAlD
Phentermine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00643	0.0115	CcSEcCtD
Phentermine—Fatigue—Fingolimod—multiple sclerosis	0.00643	0.0114	CcSEcCtD
Phentermine—SLC6A3—spinal cord—multiple sclerosis	0.00636	0.0223	CbGeAlD
Phentermine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00628	0.0473	CbGpPWpGaD
Phentermine—MAOB—medulla oblongata—multiple sclerosis	0.00621	0.0217	CbGeAlD
Phentermine—SLC6A4—midbrain—multiple sclerosis	0.00597	0.0209	CbGeAlD
Phentermine—SLC6A4—spinal cord—multiple sclerosis	0.00582	0.0204	CbGeAlD
Phentermine—Cardiac failure—Mitoxantrone—multiple sclerosis	0.00579	0.0103	CcSEcCtD
Phentermine—SLC6A2—medulla oblongata—multiple sclerosis	0.00575	0.0201	CbGeAlD
Phentermine—MAOB—midbrain—multiple sclerosis	0.00568	0.0199	CbGeAlD
Phentermine—MAOB—spinal cord—multiple sclerosis	0.00554	0.0194	CbGeAlD
Phentermine—Euphoric mood—Prednisolone—multiple sclerosis	0.00549	0.00977	CcSEcCtD
Phentermine—SLC6A3—nervous system—multiple sclerosis	0.00536	0.0188	CbGeAlD
Phentermine—Asthenia—Fingolimod—multiple sclerosis	0.00535	0.00952	CcSEcCtD
Phentermine—MAOA—medulla oblongata—multiple sclerosis	0.0053	0.0186	CbGeAlD
Phentermine—SLC6A3—central nervous system—multiple sclerosis	0.00516	0.0181	CbGeAlD
Phentermine—Ephedrine—BCHE—multiple sclerosis	0.00512	0.256	CrCbGaD
Phentermine—Diarrhoea—Fingolimod—multiple sclerosis	0.0051	0.00908	CcSEcCtD
Phentermine—Euphoric mood—Triamcinolone—multiple sclerosis	0.00505	0.00898	CcSEcCtD
Phentermine—SLC6A3—cerebellum—multiple sclerosis	0.00504	0.0176	CbGeAlD
Phentermine—Euphoric mood—Methylprednisolone—multiple sclerosis	0.00503	0.00896	CcSEcCtD
Phentermine—Dizziness—Fingolimod—multiple sclerosis	0.00493	0.00877	CcSEcCtD
Phentermine—SLC6A4—nervous system—multiple sclerosis	0.00491	0.0172	CbGeAlD
Phentermine—MAOA—midbrain—multiple sclerosis	0.00484	0.017	CbGeAlD
Phentermine—SLC6A4—central nervous system—multiple sclerosis	0.00472	0.0165	CbGeAlD
Phentermine—MAOA—spinal cord—multiple sclerosis	0.00472	0.0165	CbGeAlD
Phentermine—Headache—Fingolimod—multiple sclerosis	0.00467	0.00831	CcSEcCtD
Phentermine—MAOB—nervous system—multiple sclerosis	0.00467	0.0163	CbGeAlD
Phentermine—Euphoric mood—Dexamethasone—multiple sclerosis	0.00458	0.00815	CcSEcCtD
Phentermine—Euphoric mood—Betamethasone—multiple sclerosis	0.00458	0.00815	CcSEcCtD
Phentermine—CYP2D6—brainstem—multiple sclerosis	0.00452	0.0158	CbGeAlD
Phentermine—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.0045	0.00801	CcSEcCtD
Phentermine—MAOB—central nervous system—multiple sclerosis	0.00449	0.0157	CbGeAlD
Phentermine—Cardiac arrest—Prednisolone—multiple sclerosis	0.00441	0.00785	CcSEcCtD
Phentermine—Chest pain—Cladribine—multiple sclerosis	0.00441	0.00785	CcSEcCtD
Phentermine—MAOB—cerebellum—multiple sclerosis	0.00439	0.0154	CbGeAlD
Phentermine—Cardiac failure—Methylprednisolone—multiple sclerosis	0.00436	0.00776	CcSEcCtD
Phentermine—SLC6A2—nervous system—multiple sclerosis	0.00432	0.0151	CbGeAlD
Phentermine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.00429	0.00764	CcSEcCtD
Phentermine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00427	0.0076	CcSEcCtD
Phentermine—Oedema—Cladribine—multiple sclerosis	0.00422	0.00752	CcSEcCtD
Phentermine—SLC6A2—central nervous system—multiple sclerosis	0.00416	0.0146	CbGeAlD
Phentermine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.00415	0.0074	CcSEcCtD
Phentermine—Tachycardia—Cladribine—multiple sclerosis	0.00412	0.00734	CcSEcCtD
Phentermine—SLC6A3—brain—multiple sclerosis	0.00409	0.0143	CbGeAlD
Phentermine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.00405	0.00722	CcSEcCtD
Phentermine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00404	0.0072	CcSEcCtD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.004	0.0302	CbGpPWpGaD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.004	0.0302	CbGpPWpGaD
Phentermine—Euphoric mood—Prednisone—multiple sclerosis	0.00399	0.0071	CcSEcCtD
Phentermine—MAOA—nervous system—multiple sclerosis	0.00398	0.0139	CbGeAlD
Phentermine—Cardiac failure—Betamethasone—multiple sclerosis	0.00396	0.00706	CcSEcCtD
Phentermine—Cardiac failure—Dexamethasone—multiple sclerosis	0.00396	0.00706	CcSEcCtD
Phentermine—MAOA—central nervous system—multiple sclerosis	0.00383	0.0134	CbGeAlD
Phentermine—Insomnia—Cladribine—multiple sclerosis	0.00382	0.0068	CcSEcCtD
Phentermine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.00378	0.00673	CcSEcCtD
Phentermine—Psychotic disorder—Betamethasone—multiple sclerosis	0.00378	0.00673	CcSEcCtD
Phentermine—Pseudoephedrine—TNF—multiple sclerosis	0.00377	0.188	CrCbGaD
Phentermine—SLC6A4—brain—multiple sclerosis	0.00375	0.0131	CbGeAlD
Phentermine—MAOA—cerebellum—multiple sclerosis	0.00375	0.0131	CbGeAlD
Phentermine—Cardiac arrest—Betamethasone—multiple sclerosis	0.00368	0.00655	CcSEcCtD
Phentermine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00368	0.00655	CcSEcCtD
Phentermine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00365	0.00649	CcSEcCtD
Phentermine—Fatigue—Cladribine—multiple sclerosis	0.00364	0.00649	CcSEcCtD
Phentermine—Constipation—Cladribine—multiple sclerosis	0.00361	0.00643	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.0036	0.0272	CbGpPWpGaD
Phentermine—MAOB—brain—multiple sclerosis	0.00357	0.0125	CbGeAlD
Phentermine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.00352	0.00627	CcSEcCtD
Phentermine—Myocardial infarction—Prednisolone—multiple sclerosis	0.0035	0.00623	CcSEcCtD
Phentermine—Cardiac failure—Prednisone—multiple sclerosis	0.00345	0.00615	CcSEcCtD
Phentermine—Urticaria—Cladribine—multiple sclerosis	0.00336	0.00598	CcSEcCtD
Phentermine—Abdominal pain—Cladribine—multiple sclerosis	0.00334	0.00595	CcSEcCtD
Phentermine—SLC6A2—brain—multiple sclerosis	0.0033	0.0116	CbGeAlD
Phentermine—Psychotic disorder—Prednisone—multiple sclerosis	0.00329	0.00586	CcSEcCtD
Phentermine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00324	0.00577	CcSEcCtD
Phentermine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00323	0.00575	CcSEcCtD
Phentermine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00322	0.00573	CcSEcCtD
Phentermine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00321	0.00572	CcSEcCtD
Phentermine—Cardiac arrest—Prednisone—multiple sclerosis	0.0032	0.0057	CcSEcCtD
Phentermine—MAOA—brain—multiple sclerosis	0.00304	0.0107	CbGeAlD
Phentermine—Asthenia—Cladribine—multiple sclerosis	0.00303	0.0054	CcSEcCtD
Phentermine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00297	0.00528	CcSEcCtD
Phentermine—MAOA—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00295	0.0223	CbGpPWpGaD
Phentermine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.00294	0.00523	CcSEcCtD
Phentermine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.00294	0.00523	CcSEcCtD
Phentermine—Hypertension—Mitoxantrone—multiple sclerosis	0.00294	0.00523	CcSEcCtD
Phentermine—Hallucination—Methylprednisolone—multiple sclerosis	0.00293	0.00521	CcSEcCtD
Phentermine—Myocardial infarction—Betamethasone—multiple sclerosis	0.00292	0.0052	CcSEcCtD
Phentermine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00292	0.0052	CcSEcCtD
Phentermine—Chest pain—Mitoxantrone—multiple sclerosis	0.0029	0.00516	CcSEcCtD
Phentermine—Diarrhoea—Cladribine—multiple sclerosis	0.00289	0.00515	CcSEcCtD
Phentermine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.00287	0.00511	CcSEcCtD
Phentermine—Dizziness—Cladribine—multiple sclerosis	0.00279	0.00497	CcSEcCtD
Phentermine—Oedema—Mitoxantrone—multiple sclerosis	0.00278	0.00494	CcSEcCtD
Phentermine—Abdominal pain—Azathioprine—multiple sclerosis	0.00272	0.00483	CcSEcCtD
Phentermine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00271	0.00483	CcSEcCtD
Phentermine—Vomiting—Cladribine—multiple sclerosis	0.00269	0.00478	CcSEcCtD
Phentermine—Erectile dysfunction—Prednisone—multiple sclerosis	0.00268	0.00477	CcSEcCtD
Phentermine—Rash—Cladribine—multiple sclerosis	0.00266	0.00474	CcSEcCtD
Phentermine—Hallucination—Dexamethasone—multiple sclerosis	0.00266	0.00474	CcSEcCtD
Phentermine—Hallucination—Betamethasone—multiple sclerosis	0.00266	0.00474	CcSEcCtD
Phentermine—Dermatitis—Cladribine—multiple sclerosis	0.00266	0.00474	CcSEcCtD
Phentermine—Headache—Cladribine—multiple sclerosis	0.00265	0.00471	CcSEcCtD
Phentermine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00256	0.00456	CcSEcCtD
Phentermine—Myocardial infarction—Prednisone—multiple sclerosis	0.00254	0.00453	CcSEcCtD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00251	0.0189	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00251	0.0189	CbGpPWpGaD
Phentermine—Nausea—Cladribine—multiple sclerosis	0.00251	0.00447	CcSEcCtD
Phentermine—SLC6A4—Serotonin Transporter Activity—IL1B—multiple sclerosis	0.00245	0.0185	CbGpPWpGaD
Phentermine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00244	0.00435	CcSEcCtD
Phentermine—Hypertension—Prednisolone—multiple sclerosis	0.00241	0.00429	CcSEcCtD
Phentermine—Fatigue—Mitoxantrone—multiple sclerosis	0.00239	0.00426	CcSEcCtD
Phentermine—Constipation—Mitoxantrone—multiple sclerosis	0.00237	0.00423	CcSEcCtD
Phentermine—CYP2D6—nervous system—multiple sclerosis	0.00237	0.00828	CbGeAlD
Phentermine—Diarrhoea—Azathioprine—multiple sclerosis	0.00235	0.00418	CcSEcCtD
Phentermine—Hallucination—Prednisone—multiple sclerosis	0.00232	0.00413	CcSEcCtD
Phentermine—Oedema—Prednisolone—multiple sclerosis	0.00228	0.00406	CcSEcCtD
Phentermine—CYP2D6—central nervous system—multiple sclerosis	0.00228	0.00798	CbGeAlD
Phentermine—Dizziness—Azathioprine—multiple sclerosis	0.00227	0.00404	CcSEcCtD
Phentermine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00224	0.00399	CcSEcCtD
Phentermine—CYP2D6—cerebellum—multiple sclerosis	0.00223	0.00779	CbGeAlD
Phentermine—Tachycardia—Prednisolone—multiple sclerosis	0.00222	0.00396	CcSEcCtD
Phentermine—Hypertension—Triamcinolone—multiple sclerosis	0.00222	0.00395	CcSEcCtD
Phentermine—Hypertension—Methylprednisolone—multiple sclerosis	0.00221	0.00394	CcSEcCtD
Phentermine—Urticaria—Mitoxantrone—multiple sclerosis	0.00221	0.00393	CcSEcCtD
Phentermine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.0022	0.00391	CcSEcCtD
Phentermine—Vomiting—Azathioprine—multiple sclerosis	0.00218	0.00389	CcSEcCtD
Phentermine—Rash—Azathioprine—multiple sclerosis	0.00217	0.00386	CcSEcCtD
Phentermine—Dermatitis—Azathioprine—multiple sclerosis	0.00216	0.00385	CcSEcCtD
Phentermine—Headache—Azathioprine—multiple sclerosis	0.00215	0.00383	CcSEcCtD
Phentermine—Dry mouth—Triamcinolone—multiple sclerosis	0.00214	0.00381	CcSEcCtD
Phentermine—MAOB—Biological oxidations—CYP27B1—multiple sclerosis	0.00213	0.016	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—CYP24A1—multiple sclerosis	0.00213	0.016	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00211	0.0159	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00211	0.0159	CbGpPWpGaD
Phentermine—Oedema—Triamcinolone—multiple sclerosis	0.0021	0.00373	CcSEcCtD
Phentermine—Insomnia—Prednisolone—multiple sclerosis	0.00206	0.00367	CcSEcCtD
Phentermine—Tachycardia—Triamcinolone—multiple sclerosis	0.00204	0.00364	CcSEcCtD
Phentermine—Nausea—Azathioprine—multiple sclerosis	0.00204	0.00363	CcSEcCtD
Phentermine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00204	0.00363	CcSEcCtD
Phentermine—Hypertension—Dexamethasone—multiple sclerosis	0.00201	0.00358	CcSEcCtD
Phentermine—Hypertension—Betamethasone—multiple sclerosis	0.00201	0.00358	CcSEcCtD
Phentermine—MAOA—Serotonin Transporter Activity—IL1B—multiple sclerosis	0.00201	0.0151	CbGpPWpGaD
Phentermine—Asthenia—Mitoxantrone—multiple sclerosis	0.00199	0.00355	CcSEcCtD
Phentermine—Oedema—Dexamethasone—multiple sclerosis	0.0019	0.00338	CcSEcCtD
Phentermine—Oedema—Betamethasone—multiple sclerosis	0.0019	0.00338	CcSEcCtD
Phentermine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.0019	0.00338	CcSEcCtD
Phentermine—Insomnia—Triamcinolone—multiple sclerosis	0.00189	0.00337	CcSEcCtD
Phentermine—Insomnia—Methylprednisolone—multiple sclerosis	0.00189	0.00337	CcSEcCtD
Phentermine—Agitation—Prednisone—multiple sclerosis	0.00186	0.00332	CcSEcCtD
Phentermine—Tachycardia—Dexamethasone—multiple sclerosis	0.00186	0.0033	CcSEcCtD
Phentermine—Tachycardia—Betamethasone—multiple sclerosis	0.00186	0.0033	CcSEcCtD
Phentermine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00184	0.00328	CcSEcCtD
Phentermine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00184	0.00328	CcSEcCtD
Phentermine—Urticaria—Prednisolone—multiple sclerosis	0.00181	0.00322	CcSEcCtD
Phentermine—CYP2D6—brain—multiple sclerosis	0.00181	0.00633	CbGeAlD
Phentermine—Fatigue—Triamcinolone—multiple sclerosis	0.00181	0.00322	CcSEcCtD
Phentermine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0018	0.0136	CbGpPWpGaD
Phentermine—Fatigue—Methylprednisolone—multiple sclerosis	0.0018	0.00321	CcSEcCtD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.0018	0.0136	CbGpPWpGaD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.0018	0.0136	CbGpPWpGaD
Phentermine—Vomiting—Mitoxantrone—multiple sclerosis	0.00177	0.00314	CcSEcCtD
Phentermine—Hypertension—Prednisone—multiple sclerosis	0.00175	0.00312	CcSEcCtD
Phentermine—Rash—Mitoxantrone—multiple sclerosis	0.00175	0.00312	CcSEcCtD
Phentermine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00175	0.00311	CcSEcCtD
Phentermine—Headache—Mitoxantrone—multiple sclerosis	0.00174	0.0031	CcSEcCtD
Phentermine—Insomnia—Betamethasone—multiple sclerosis	0.00172	0.00306	CcSEcCtD
Phentermine—Insomnia—Dexamethasone—multiple sclerosis	0.00172	0.00306	CcSEcCtD
Phentermine—Dyspepsia—Betamethasone—multiple sclerosis	0.00167	0.00298	CcSEcCtD
Phentermine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00167	0.00298	CcSEcCtD
Phentermine—Urticaria—Triamcinolone—multiple sclerosis	0.00166	0.00296	CcSEcCtD
Phentermine—Urticaria—Methylprednisolone—multiple sclerosis	0.00166	0.00296	CcSEcCtD
Phentermine—Oedema—Prednisone—multiple sclerosis	0.00166	0.00295	CcSEcCtD
Phentermine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00165	0.00294	CcSEcCtD
Phentermine—Nausea—Mitoxantrone—multiple sclerosis	0.00165	0.00294	CcSEcCtD
Phentermine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00164	0.00292	CcSEcCtD
Phentermine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00164	0.00292	CcSEcCtD
Phentermine—Fatigue—Dexamethasone—multiple sclerosis	0.00164	0.00292	CcSEcCtD
Phentermine—Fatigue—Betamethasone—multiple sclerosis	0.00164	0.00292	CcSEcCtD
Phentermine—Tachycardia—Prednisone—multiple sclerosis	0.00162	0.00288	CcSEcCtD
Phentermine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.0016	0.012	CbGpPWpGaD
Phentermine—Urticaria—Dexamethasone—multiple sclerosis	0.00151	0.00269	CcSEcCtD
Phentermine—Urticaria—Betamethasone—multiple sclerosis	0.00151	0.00269	CcSEcCtD
Phentermine—Dizziness—Prednisolone—multiple sclerosis	0.00151	0.00268	CcSEcCtD
Phentermine—Asthenia—Triamcinolone—multiple sclerosis	0.0015	0.00268	CcSEcCtD
Phentermine—Abdominal pain—Dexamethasone—multiple sclerosis	0.0015	0.00268	CcSEcCtD
Phentermine—Abdominal pain—Betamethasone—multiple sclerosis	0.0015	0.00268	CcSEcCtD
Phentermine—Asthenia—Methylprednisolone—multiple sclerosis	0.0015	0.00267	CcSEcCtD
Phentermine—Insomnia—Prednisone—multiple sclerosis	0.0015	0.00267	CcSEcCtD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.0015	0.0113	CbGpPWpGaD
Phentermine—Dyspepsia—Prednisone—multiple sclerosis	0.00146	0.00259	CcSEcCtD
Phentermine—MAOA—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00145	0.0109	CbGpPWpGaD
Phentermine—Chest pain—Methotrexate—multiple sclerosis	0.00144	0.00257	CcSEcCtD
Phentermine—Rash—Prednisolone—multiple sclerosis	0.00144	0.00256	CcSEcCtD
Phentermine—Dermatitis—Prednisolone—multiple sclerosis	0.00144	0.00256	CcSEcCtD
Phentermine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00143	0.00255	CcSEcCtD
Phentermine—Fatigue—Prednisone—multiple sclerosis	0.00143	0.00254	CcSEcCtD
Phentermine—Headache—Prednisolone—multiple sclerosis	0.00143	0.00254	CcSEcCtD
Phentermine—Constipation—Prednisone—multiple sclerosis	0.00142	0.00252	CcSEcCtD
Phentermine—MAOA—Neuronal System—KCNA3—multiple sclerosis	0.00141	0.0106	CbGpPWpGaD
Phentermine—Dizziness—Triamcinolone—multiple sclerosis	0.00139	0.00247	CcSEcCtD
Phentermine—Dizziness—Methylprednisolone—multiple sclerosis	0.00138	0.00246	CcSEcCtD
Phentermine—Asthenia—Betamethasone—multiple sclerosis	0.00136	0.00243	CcSEcCtD
Phentermine—Asthenia—Dexamethasone—multiple sclerosis	0.00136	0.00243	CcSEcCtD
Phentermine—Nausea—Prednisolone—multiple sclerosis	0.00135	0.00241	CcSEcCtD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00135	0.0102	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00135	0.0102	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00134	0.0101	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00134	0.0101	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP24A1—multiple sclerosis	0.00133	0.0101	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP27B1—multiple sclerosis	0.00133	0.0101	CbGpPWpGaD
Phentermine—Vomiting—Triamcinolone—multiple sclerosis	0.00133	0.00237	CcSEcCtD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00133	0.01	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00133	0.01	CbGpPWpGaD
Phentermine—Vomiting—Methylprednisolone—multiple sclerosis	0.00133	0.00237	CcSEcCtD
Phentermine—Rash—Triamcinolone—multiple sclerosis	0.00132	0.00235	CcSEcCtD
Phentermine—Dermatitis—Triamcinolone—multiple sclerosis	0.00132	0.00235	CcSEcCtD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00132	0.00994	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00132	0.00994	CbGpPWpGaD
Phentermine—Rash—Methylprednisolone—multiple sclerosis	0.00132	0.00235	CcSEcCtD
Phentermine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00132	0.00234	CcSEcCtD
Phentermine—Urticaria—Prednisone—multiple sclerosis	0.00132	0.00234	CcSEcCtD
Phentermine—Headache—Triamcinolone—multiple sclerosis	0.00131	0.00234	CcSEcCtD
Phentermine—Headache—Methylprednisolone—multiple sclerosis	0.00131	0.00233	CcSEcCtD
Phentermine—Abdominal pain—Prednisone—multiple sclerosis	0.00131	0.00233	CcSEcCtD
Phentermine—SLC6A3—Neuronal System—KCNA3—multiple sclerosis	0.00131	0.00985	CbGpPWpGaD
Phentermine—Diarrhoea—Betamethasone—multiple sclerosis	0.0013	0.00232	CcSEcCtD
Phentermine—Diarrhoea—Dexamethasone—multiple sclerosis	0.0013	0.00232	CcSEcCtD
Phentermine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00126	0.0095	CbGpPWpGaD
Phentermine—Dizziness—Betamethasone—multiple sclerosis	0.00126	0.00224	CcSEcCtD
Phentermine—Dizziness—Dexamethasone—multiple sclerosis	0.00126	0.00224	CcSEcCtD
Phentermine—Insomnia—Methotrexate—multiple sclerosis	0.00125	0.00223	CcSEcCtD
Phentermine—Nausea—Triamcinolone—multiple sclerosis	0.00124	0.00222	CcSEcCtD
Phentermine—Nausea—Methylprednisolone—multiple sclerosis	0.00124	0.00221	CcSEcCtD
Phentermine—MAOA—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00123	0.00924	CbGpPWpGaD
Phentermine—Dyspepsia—Methotrexate—multiple sclerosis	0.00122	0.00217	CcSEcCtD
Phentermine—Vomiting—Betamethasone—multiple sclerosis	0.00121	0.00215	CcSEcCtD
Phentermine—Vomiting—Dexamethasone—multiple sclerosis	0.00121	0.00215	CcSEcCtD
Phentermine—Rash—Dexamethasone—multiple sclerosis	0.0012	0.00213	CcSEcCtD
Phentermine—Rash—Betamethasone—multiple sclerosis	0.0012	0.00213	CcSEcCtD
Phentermine—Dermatitis—Betamethasone—multiple sclerosis	0.0012	0.00213	CcSEcCtD
Phentermine—Dermatitis—Dexamethasone—multiple sclerosis	0.0012	0.00213	CcSEcCtD
Phentermine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00119	0.00213	CcSEcCtD
Phentermine—Fatigue—Methotrexate—multiple sclerosis	0.00119	0.00212	CcSEcCtD
Phentermine—Headache—Betamethasone—multiple sclerosis	0.00119	0.00212	CcSEcCtD
Phentermine—Headache—Dexamethasone—multiple sclerosis	0.00119	0.00212	CcSEcCtD
Phentermine—Asthenia—Prednisone—multiple sclerosis	0.00119	0.00211	CcSEcCtD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00114	0.00861	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00114	0.00861	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.00113	0.00854	CbGpPWpGaD
Phentermine—Diarrhoea—Prednisone—multiple sclerosis	0.00113	0.00202	CcSEcCtD
Phentermine—Nausea—Dexamethasone—multiple sclerosis	0.00113	0.00201	CcSEcCtD
Phentermine—Nausea—Betamethasone—multiple sclerosis	0.00113	0.00201	CcSEcCtD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00113	0.0085	CbGpPWpGaD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00113	0.0085	CbGpPWpGaD
Phentermine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00112	0.00841	CbGpPWpGaD
Phentermine—Urticaria—Methotrexate—multiple sclerosis	0.0011	0.00196	CcSEcCtD
Phentermine—Dizziness—Prednisone—multiple sclerosis	0.00109	0.00195	CcSEcCtD
Phentermine—Abdominal pain—Methotrexate—multiple sclerosis	0.00109	0.00195	CcSEcCtD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00109	0.00824	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00109	0.00824	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00108	0.00817	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00108	0.00817	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00108	0.00815	CbGpPWpGaD
Phentermine—Vomiting—Prednisone—multiple sclerosis	0.00105	0.00187	CcSEcCtD
Phentermine—Rash—Prednisone—multiple sclerosis	0.00104	0.00186	CcSEcCtD
Phentermine—SLC6A4—Monoamine Transport—IL1B—multiple sclerosis	0.00104	0.00786	CbGpPWpGaD
Phentermine—Dermatitis—Prednisone—multiple sclerosis	0.00104	0.00186	CcSEcCtD
Phentermine—Headache—Prednisone—multiple sclerosis	0.00104	0.00185	CcSEcCtD
Phentermine—Asthenia—Methotrexate—multiple sclerosis	0.000993	0.00177	CcSEcCtD
Phentermine—Nausea—Prednisone—multiple sclerosis	0.000983	0.00175	CcSEcCtD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000979	0.00738	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000958	0.00722	CbGpPWpGaD
Phentermine—Diarrhoea—Methotrexate—multiple sclerosis	0.000947	0.00169	CcSEcCtD
Phentermine—MAOA—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000929	0.007	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000926	0.00698	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000926	0.00698	CbGpPWpGaD
Phentermine—Dizziness—Methotrexate—multiple sclerosis	0.000915	0.00163	CcSEcCtD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0009	0.00678	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—IL1B—multiple sclerosis	0.000897	0.00676	CbGpPWpGaD
Phentermine—Vomiting—Methotrexate—multiple sclerosis	0.00088	0.00157	CcSEcCtD
Phentermine—Rash—Methotrexate—multiple sclerosis	0.000872	0.00155	CcSEcCtD
Phentermine—Dermatitis—Methotrexate—multiple sclerosis	0.000872	0.00155	CcSEcCtD
Phentermine—Headache—Methotrexate—multiple sclerosis	0.000867	0.00154	CcSEcCtD
Phentermine—Nausea—Methotrexate—multiple sclerosis	0.000822	0.00146	CcSEcCtD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00082	0.00618	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—IL1B—multiple sclerosis	0.000795	0.00599	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—TNF—multiple sclerosis	0.000757	0.0057	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000726	0.00547	CbGpPWpGaD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—STAT3—multiple sclerosis	0.000701	0.00529	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000689	0.00519	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—TNF—multiple sclerosis	0.000651	0.0049	CbGpPWpGaD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—multiple sclerosis	0.00065	0.0049	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000632	0.00476	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000615	0.00463	CbGpPWpGaD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000589	0.00444	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000587	0.00442	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000581	0.00438	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000581	0.00438	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—TNF—multiple sclerosis	0.000577	0.00435	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000576	0.00434	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000576	0.00434	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000573	0.00432	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000573	0.00432	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000573	0.00432	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000568	0.00428	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000568	0.00428	CbGpPWpGaD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000565	0.00426	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.00056	0.00422	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00055	0.00414	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000543	0.0041	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000535	0.00403	CbGpPWpGaD
Phentermine—MAOB—Metabolism—SRM—multiple sclerosis	0.000516	0.00389	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000515	0.00388	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000507	0.00382	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000492	0.00371	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000492	0.00371	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000487	0.00367	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000485	0.00366	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000485	0.00366	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000481	0.00362	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000478	0.0036	CbGpPWpGaD
Phentermine—MAOB—Biological oxidations—POMC—multiple sclerosis	0.000478	0.0036	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000459	0.00346	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000417	0.00314	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—FAS—multiple sclerosis	0.00041	0.00309	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—BCHE—multiple sclerosis	0.000394	0.00297	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000369	0.00278	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—BCHE—multiple sclerosis	0.000366	0.00276	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP24A1—multiple sclerosis	0.000364	0.00274	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP27B1—multiple sclerosis	0.000364	0.00274	CbGpPWpGaD
Phentermine—MAOB—Metabolism—GPC5—multiple sclerosis	0.000332	0.00251	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000329	0.00248	CbGpPWpGaD
Phentermine—MAOA—Metabolism—SRM—multiple sclerosis	0.000324	0.00244	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000303	0.00229	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000301	0.00227	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—POMC—multiple sclerosis	0.0003	0.00226	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000294	0.00221	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000292	0.0022	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000291	0.00219	CbGpPWpGaD
Phentermine—MAOB—Metabolism—RRM1—multiple sclerosis	0.000276	0.00208	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000264	0.00199	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000258	0.00194	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000257	0.00194	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000246	0.00185	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000244	0.00184	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000241	0.00181	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—TGFB1—multiple sclerosis	0.000241	0.00181	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000236	0.00178	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000235	0.00177	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP24A1—multiple sclerosis	0.000228	0.00172	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP27B1—multiple sclerosis	0.000228	0.00172	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000221	0.00167	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000221	0.00167	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000213	0.00161	CbGpPWpGaD
Phentermine—MAOA—Metabolism—GPC5—multiple sclerosis	0.000209	0.00157	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000208	0.00157	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	0.000207	0.00156	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000206	0.00155	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000189	0.00142	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000189	0.00142	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000184	0.00138	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—TGFB1—multiple sclerosis	0.000183	0.00138	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000183	0.00138	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000183	0.00138	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.00018	0.00135	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000175	0.00132	CbGpPWpGaD
Phentermine—MAOA—Metabolism—RRM1—multiple sclerosis	0.000173	0.0013	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000172	0.0013	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000171	0.00129	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000171	0.00129	CbGpPWpGaD
Phentermine—MAOB—Metabolism—BCHE—multiple sclerosis	0.000158	0.00119	CbGpPWpGaD
Phentermine—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00015	0.00113	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000141	0.00106	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000141	0.00106	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—IL6—multiple sclerosis	0.00014	0.00106	CbGpPWpGaD
Phentermine—SLC6A3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00014	0.00105	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—SRM—multiple sclerosis	0.00014	0.00105	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000131	0.000984	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	0.00013	0.000976	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—SRM—multiple sclerosis	0.000119	0.0009	CbGpPWpGaD
Phentermine—MAOA—Neuronal System—MAPK1—multiple sclerosis	0.000115	0.000868	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	0.000111	0.000834	CbGpPWpGaD
Phentermine—SLC6A3—Neuronal System—MAPK1—multiple sclerosis	0.000107	0.000807	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000105	0.00079	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	9.93e-05	0.000748	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	9.93e-05	0.000748	CbGpPWpGaD
Phentermine—MAOA—Metabolism—BCHE—multiple sclerosis	9.93e-05	0.000748	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	9.85e-05	0.000742	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	9.85e-05	0.000742	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.62e-05	0.000725	CbGpPWpGaD
Phentermine—MAOB—Metabolism—APOE—multiple sclerosis	9.52e-05	0.000717	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.28e-05	0.0007	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—GPC5—multiple sclerosis	9.08e-05	0.000684	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—GPC5—multiple sclerosis	9e-05	0.000679	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	8.41e-05	0.000634	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	8.41e-05	0.000634	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.22e-05	0.00062	CbGpPWpGaD
Phentermine—MAOB—Metabolism—POMC—multiple sclerosis	8.18e-05	0.000616	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—GPC5—multiple sclerosis	7.69e-05	0.00058	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—RRM1—multiple sclerosis	7.53e-05	0.000567	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—RRM1—multiple sclerosis	7.46e-05	0.000562	CbGpPWpGaD
Phentermine—MAOB—Metabolism—ALB—multiple sclerosis	7.46e-05	0.000562	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—RRM1—multiple sclerosis	6.38e-05	0.00048	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APOE—multiple sclerosis	5.97e-05	0.00045	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.79e-05	0.000436	CbGpPWpGaD
Phentermine—MAOA—Metabolism—POMC—multiple sclerosis	5.13e-05	0.000387	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.97e-05	0.000375	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.95e-05	0.000373	CbGpPWpGaD
Phentermine—MAOA—Metabolism—ALB—multiple sclerosis	4.68e-05	0.000353	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.53e-05	0.000342	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—BCHE—multiple sclerosis	4.32e-05	0.000326	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—BCHE—multiple sclerosis	4.29e-05	0.000323	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.25e-05	0.00032	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.87e-05	0.000292	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.66e-05	0.000276	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APOE—multiple sclerosis	2.6e-05	0.000196	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APOE—multiple sclerosis	2.58e-05	0.000194	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.23e-05	0.000168	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.21e-05	0.000167	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—APOE—multiple sclerosis	2.2e-05	0.000166	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.04e-05	0.000153	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.02e-05	0.000152	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.89e-05	0.000143	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.73e-05	0.00013	CbGpPWpGaD
